European Union 
Co-financing from the state budget PRICE INQUIRY no. NETLA/4/2023/API - being conducted as a market assessment study
In connection with the implementation of the project titled “Design and development of an innovative solution – a complex, two-component medicinal product in the form of eye drops in a multi-dose package without preservatives, aimed at the treatment of open-angle glaucoma”, funded from the state budget by the Medical Research Agency, WZF Polfa S.A., you are kindly requested to submit a bid for the purchase and delivery of the active substance netarsudil (in the form of netarsudil dimesylate), analytical standards of the active substance netarsudil dimesylate and impurities of the substance netarsudil. Details of the price inquiry can be found in the documents attached below.
go back